Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Brain Neoplasms × fludarabine × Clear all

Phase

Phase 1 3 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 29 Lymphoma, Non-Hodgkin 21 Leukemia 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma 19 Myelodysplastic Syndromes 17 Hematologic Neoplasms 17 Leukemia, Lymphocytic, Chronic, B-Cell 16 Melanoma 15 Lymphoma, B-Cell 13 Recurrence 12 Multiple Myeloma 12 Neoplasm Metastasis 11 Hodgkin Disease 11 Pancreatic Neoplasms 9 Ovarian Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Breast Neoplasms 8 Stomach Neoplasms 7 Lymphoma, Mantle-Cell 7 Lymphoma, Follicular 7 Uterine Cervical Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Burkitt Lymphoma 5 Myeloproliferative Disorders 4 Lymphoproliferative Disorders 4 Lung Neoplasms 4 Kidney Neoplasms 4

Interventions

Temozolomide 23 Radiosurgery 12 Bevacizumab 11 Carboplatin 8 pembrolizumab 7 Radiotherapy 7 Trastuzumab 6 Erlotinib Hydrochloride 5 abemaciclib 4 Paclitaxel 4 Capecitabine 4 tipifarnib 3 temsirolimus 3 Sirolimus 3 Radiation 3 Irinotecan 3 Ipilimumab 3 Everolimus 3 Aminolevulinic Acid 3 tucatinib 2 pertuzumab 2 durvalumab 2 alovudine 2 Vorinostat 2 Surgical Procedures, Operative 2 Sorafenib 2 Nivolumab 2 NVP-BKM120 2 Mental Status and Dementia Tests 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡